These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade. Xu H, Huang Y, Hussain LR, Zhu Z, Bozulic LD, Ding C, Yan J, Ildstad ST. Am J Transplant; 2010 Jul; 10(7):1569-79. PubMed ID: 20642683 [Abstract] [Full Text] [Related]
8. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation. Kim EY, Lee EN, Lee J, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Joh JW, Kim SJ. Exp Mol Med; 2006 Jun 30; 38(3):284-94. PubMed ID: 16819287 [Abstract] [Full Text] [Related]
16. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants. Qian Y, Boisgerault F, Benichou G, Dana MR. Invest Ophthalmol Vis Sci; 2001 Apr 30; 42(5):987-94. PubMed ID: 11274076 [Abstract] [Full Text] [Related]
17. Neutralizing IL-7 promotes long-term allograft survival induced by CD40/CD40L costimulatory blockade. Wang Y, Dai H, Liu Z, Cheng X, Tellides G, Dai Z. Am J Transplant; 2006 Dec 30; 6(12):2851-60. PubMed ID: 17062001 [Abstract] [Full Text] [Related]